title: A qualitative analysis of brain SPECT for prognostication of gross motor development in children with cerebral palsy.
abstract: OBJECTIVE
  In this report, the authors assessed the clinical significance of decreased regional cerebral blood flow (rCBF) in the thalamus or cerebellar hemispheres in relation to gross motor performance in the children with cerebral palsy.
  
  
  METHODS
  Thirty-six children with bilateral spastic cerebral palsy (BSCP) underwent brain SPECT. Visual analysis was used for the brain SPECT interpretation. The rCBF in the thalamus or cerebellum was graded as normal, mildly decreased, or severely decreased. A marked decrease or near absence of rCBF in the thalamus or cerebellum was considered as severely decreased.
  
  
  RESULTS
  All 36 children with BSCP had hypoperfusion in the thalamus or cerebellar hemispheres. Eight of 20 children (40%) with mildly decreased rCBF on brain SPECT had mild developmental delays. On the other hand, only 1 of 16 children (6.3%) with severe hypoperfusion in the thalamus or cerebellum had a mild developmental delay, and the remaining 15 of 16 children (93.8%) had severe developmental delays. There was good correlation between the degree of developmental delay and the severity of hypoperfusion in the thalamus or cerebellum (P = 0.023).
  
  
  CONCLUSIONS
  The measurement of rCBF by Tc-99m ethyl cysteinate dimer brain SPECT appears to be valuable in prognostication of gross motor development in children with BSCP.
authors.affiliation: Department of Physical Medicine and Rehabilitation, Ajou University School of Medicine, Suwon, Korea.
authors.forename: S Y
authors.initials: SY
authors.lastname: Yim
authors.forename: I Y
authors.initials: IY
authors.lastname: Lee
authors.forename: C H
authors.initials: CH
authors.lastname: Park
authors.forename: O H
authors.initials: OH
authors.lastname: Kim
mesh_terms: D001921:Brain / Q000000981:diagnostic imaging* / Q000503:physiopathology; D002531:Cerebellum / Q000098:blood supply; D002547:Cerebral Palsy / Q000000981:diagnostic imaging* / Q000503:physiopathology; D002560:Cerebrovascular Circulation / Q000502:physiology; D003545:Cysteine / Q000031:analogs & derivatives; D002658:Developmental Disabilities / Q000453:epidemiology; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D009048:Motor Skills / Q000502:physiology*; D015609:Organotechnetium Compounds; D011237:Predictive Value of Tests; D019275:Radiopharmaceuticals; D013788:Thalamus / Q000098:blood supply; D015899:Tomography, Emission-Computed, Single-Photon
chemical_list: D015609:Organotechnetium Compounds; D019275:Radiopharmaceuticals; C059659:technetium Tc 99m bicisate; D003545:Cysteine